By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Nunzia Pharmaceutical Company (NUNZ)

OTC Currency in USD
$0.00
$0.00
-96.67%
Last Update: 29 Aug 2025, 00:00
$43.45K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

NUNZ Stock Price Chart

Explore Nunzia Pharmaceutical Company interactive price chart. Choose custom timeframes to analyze NUNZ price movements and trends.

NUNZ Company Profile

Discover essential business fundamentals and corporate details for Nunzia Pharmaceutical Company (NUNZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

24 Jul 2009

Employees

CEO

Sara P. Gonzales

Description

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

NUNZ Financial Timeline

Browse a chronological timeline of Nunzia Pharmaceutical Company corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

NUNZ Stock Performance

Access detailed NUNZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run